The demand for medical-use cannabis in Israel A
Post# of 4861
According to IMCA data, the demand for medical cannabis is growing rapidly, with 80,000 patients seeking the product.
The local growers in Israel struggle to satisfy the demand. Following the efforts to legalize cannabis for recreational use, the requirement will grow to 2.5 million customers for the local industry.
Darryl Jones states that the CEO of Isracann said the importation license is a win-win strategy for both firms. It is now time for the serious operators to plan their strategy considering the impending demand for medical-use cannabis and recreational cannabis.
Jones said the company is in discussions with large cannabis players to clinch the opportunities and satisfy the growing demand. It expects to make some commercial decisions soon.
https://factsaboutcbd.org/isracann-bioscience...anada-4165
If you are looking for stocks with good return, Isracann Biosciences Inc can be a profitable investment option. ... Based on our forecasts, a long-term increase is expected, the "ATLED" stock price prognosis for 2024-11-13 is 4.009 USD. With a 5-year investment, the revenue is expected to be around +1282.44%.
TOODLES